Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Tina Costacou
Personal Information
Title
Assistant Professor
Expertise
Nephropathy
Institution
University of Pittsburgh-Main Campus
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
3
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
Kidney IRon by HAptoglobin genotype (KIRHA)
Young adults with type 1 diabetes (T1D) exhibit dramatically higher cardiorenal disease rates despite only minor risk factor differences vs. the general population. Thus, there is a critical need to identify currently unrecognized sources of increased susceptibility to vascular T1D complications. In the absence of such knowledge, the development of effective prevention strategies to address the excess cardiorenal rates in T1D will likely remain challenging. In the past decade, the Haptoglobin (Hp) 2-2 genotype has risen as a major contributor to T1D/T2D complication risk. Our long term goal is to identify the mechanisms by which Hp 2-2 contributes to T1D/T2D cardiorenal risk, in order to develop optimal intervention strategies to reduce/eliminate the genetic susceptibility conferred by Hp 2-2. Our objective in this pilot study is to lay the foundations for the identification of the biologic mechanisms by which this established functional variant, Hp, affects predisposition to T1D kidney disease. Our central hypothesis is that Hp 2-2 is associated with increased kidney iron deposition and proximal tubular injury, leading to declining kidney function and progression to end-stage renal disease (ESRD) in T1D. With this project we will obtain preliminary data on kidney iron as well as on the concentration of biomarkers of proximal tubular injury and oxidation by Hp genotype 1-1 or 2-2 in individuals with T1D. Individuals with T1D and known Hp genotype will be recruited from participants of the Pittsburgh Epidemiology of Diabetes Complications (EDC) study (PI: Orchard) attending the 30 year follow-up examination or from the HapE study (PI: Costacou). The preliminary data generated in this project will aid the subsequent submission of an R01 application to fully assess this hypothesis in a larger sample, including all Hp genotypes (1-1, 2-1 and 2-2) and also assessing the potential beneficial effects of treatment with the antioxidant vitamin E (given existing data of benefit against coronary heart disease among those with diabetes and Hp 2-2) and/or chelation therapy (in which the consortium has expressed interest) in the genetically susceptible group with T1D and the Hp 2-2 genotype (>40% of the T1D population).
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Kidney IRon by HAptoglobin genotype (KIRHA) (Costacou, Tina)
12/29/2016
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Year: 2018; Items: 1
Is Magnetic Resonance Imaging Detection of Kidney Iron Deposition Increased in Haptoglobin 2-2 Genotype Carriers with Type 1 Diabetes?
Costacou T, Orchard TJ, Moon CH, Bae KT, Fried L, Evans RW
Antioxidants & redox signaling
, 2018
Costacou, Tina
29298491
Published
Year: 2016; Items: 2
Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, Orchard TJ
Acta diabetologica
, 2016 (53), 243 - 50
Costacou, Tina
26002590
Published
The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T, Orchard TJ
Journal of diabetes and its complications
, 2016 (30), 221 - 6
Costacou, Tina
26684170
Published
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Nephropathy
The DiaComp Nephropathy Committee has the principal function of furthering the mission of the consortium with regard to diabetic kidney disease.
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!